Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tumor-specific antigen solubilized by hypertonic potassium chloride.

× No keyword cloud information.

39 in total

1. Some perspectives on the transfer of cell-mediated immunity by immune-RNA.

Authors: S Dray; D P Braun
Journal: Mol Cell Biochem Date: 1979-05-06 Impact factor: 3.396

2. Lymphocytotoxicity to tumor target cells and interference of serum factors or tumor antigen with lymphocytotoxicity in patients suffering from different stages of breast carcinoma.

Authors: H Warnatz; D Lackner; E Eder; F Scheiffarth; M Gruhl; O Bischoff
Journal: Z Krebsforsch Klin Onkol Cancer Res Clin Oncol Date: 1976-02-25

3. Relationship between general or specific immunoreactivity and prognosis in postoperative patients with hepatocellular carcinoma.

Authors: H Yamasaki; E Okamoto; T Komatsu; Y Manabe; S Shinka
Journal: Cancer Immunol Immunother Date: 1990 Impact factor: 6.968

4. Assessment of coxsackievirus B3 ts mutants for induction of myocarditis in a murine model.

Authors: M D Trousdale; R E Paque; T Nealon; C J Gauntt
Journal: Infect Immun Date: 1979-02 Impact factor: 3.441

5. [Influence of autologous serum on leucocyte-migration-inhibition-test in melanomalignoma (author's transl)].

Authors: J Fritz; K Grond
Journal: Arch Dermatol Res Date: 1977-04-27 Impact factor: 3.017

6. Regulation of leukocyte glass adherence and tube leukocyte adherence inhibition (LAI) reactivity by serum factors in dogs with progressing or spontaneously regressing canine transmissible venereal sarcoma (CTVS).

Authors: M W Harding; T J Yang
Journal: Cancer Immunol Immunother Date: 1985 Impact factor: 6.968

7. Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.

Authors: C J Gauntt; R E Paque; M D Trousdale; R J Gudvangen; D T Barr; G J Lipotich; T J Nealon; P S Duffey
Journal: Infect Immun Date: 1983-02 Impact factor: 3.441

8. Generation of tumor-specific cytotoxic T lymphocytes in vivo by combined treatment with inactivated tumor cells and recombinant interleukin-2.

Authors: M Harada; G Matsuzaki; Y Shinomiya; S Kurosawa; O Ito; T Okamoto; M Takenoyama; H Sumitika; Y Nishimura; K Nomoto
Journal: Cancer Immunol Immunother Date: 1994-05 Impact factor: 6.968

9. Tumor-reactive IgE antibodies in plasma of patients with gastrointestinal carcinomas.

Authors: I Berczi; V Holford-Strevens; Z H Warsi; L S McMorris; R H Thorlakson; T K Thorlakson; A H Sehon
Journal: Cancer Immunol Immunother Date: 1983 Impact factor: 6.968

10. Tumour rejection after adoptive transfer of line-10-immune spleen cells is mediated by two T cell subpopulations.

Authors: P A Steerenberg; E Geerse; W H De Jong; R Burger; R J Scheper; W Den Otter
Journal: Cancer Immunol Immunother Date: 1991 Impact factor: 6.968